This underscores an uncertainty around whether an underlying structural lesion is always the true epileptogenic basis of NF1 epilepsy, or whether there are molecular alterations, driven by disease-associated loss-of-function mutations in Nf1, that mediate NF1-associated hyperexcitability. This evidence concerns the gene NF1 and epilepsy.